Navigation Links
VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting

t can be effective in treating metastatic prostate cancer in the future.

    Presentation Title:  Combined inhibition of Cdk9 and AKT induces apoptosis

                         of metastatic prostate cancer cells


    Author Block:        Subhra Mohapatra, Baoky Chu, Xiuhua Zhao, Jin Cheng,

                         W. Jackson Pledger. H. Lee Moffitt Cancer Ctr. & Res.

                         Inst., Tampa, FL

About VioQuest Pharmaceuticals

VioQuest Pharmaceuticals, Inc. (http://www.vioquestpharm.com) focuses on acquiring, developing, and commercializing targeted late preclinical and early clinical stage therapies with unique mechanisms of action for oncology, viral and autoimmune disorders. VioQuest has two targeted therapeutics in Phase I/IIa clinic trials: VQD-002 which inhibits activation of Akt that is seen at abnormally high levels in breast, ovarian, colorectal, pancreatic, and hematologic tumors; and Lenocta (TM), an inhibitor of specific protein tyrosine phosphatases, which has shown compelling preclinical activity in both renal and melanoma cancers. In addition, VioQuest and the U.S. Army are planning to submit an NDA to the FDA in 2007 for Lenocta (TM) for the treatment of leishmaniasis. VioQuest also has recently in-licensed Xyfid (TM), a topical therapy which has shown early clinical promise in the treatment and prevention of chemo-induced hand-foot syndrome.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties that could cause VioQuest's actual results and experiences to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as anticipates, expects, plans, believes, intends, and similar words or phrases. These statements are based on cu
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:7/11/2014)... -- Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ) has ... Testing Market - Forecasts to 2019: Expected to ... is expected to be valued at USD 4,943.0 ... http://photos.prnewswire.com/prnh/20130307/600769 The ... according to immunoprotein types which include immunoglobulins, complement ...
(Date:7/11/2014)... July 11, 2014 Neurelis, Inc. ("Neurelis") today ... end the option held by Biotie to purchase Neurelis, ... of NRL-1 (intranasal diazepam) for pediatric and adult epilepsy ... the past year, Biotie has advanced the development program ... the pivotal clinical work required for NDA submission to ...
(Date:7/10/2014)... -- The U.S. Department of Health and Human Services (HHS) ... Case Medical Center Seidman Cancer Center totaling $4.7 million ... care for patients with complex cancer. ... unique model developed at UH to enhance care for ... demonstrated need for high health care utilization.  ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4
... Virtual Radiologic (vRad), a technology-enabled national radiology practice, ... solution, has been selected by Abbeville Area Medical ... South Carolina. AAMC selected vRad,s ... on-premise PACS that was developed by radiologists for ...
... NEW YORK, Nov. 29, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0693503/Medical-Devices---Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics This ... from the following Asian countries: Azerbaijan, China, ...
Cached Medicine Technology:vRad Selected by Abbeville Area Medical Center for PACS Replacement 2vRad Selected by Abbeville Area Medical Center for PACS Replacement 3Medical Devices - Asia 2
(Date:7/12/2014)... July 13, 2014 Recently, Fadhits.com, a well-known ... of elegant long graduation dresses to its product ... for its loyal clients. It wants to bring more benefits ... are now offered at discounted prices, up to 72% off. ... is always working hard. Its online shop is a good ...
(Date:7/12/2014)... York, NY (PRWEB) July 12, 2014 ... steady growth over the past five years, buoyed by ... agricultural sector's supply management system. “Eggs are a relatively ... result, per capita egg consumption generally grows in line ... Industry Analyst Will McKitterick. Furthermore, demand for new specialty ...
(Date:7/12/2014)... July 12, 2014 Fresh off their respective ... will meet on September 5th at Sun Life Stadium ... to see some of the brightest stars in the world ... in Miami will be treated to some of the best ... currently ranked as the third best team in the world ...
(Date:7/12/2014)... The report, "Phthalic Anhydride and Derivatives ... Application & Geography – Trends & Forecast to 2018," ... forecasting of market volume and value. The report also ... The market of phthalic anhydride is projected to grow ... million by 2018, with a CAGR of 5.24% from ...
(Date:7/12/2014)... The "North American Interventional ... by Angioplasty Balloon (Plain/Old, Cutting), Stent ... Filter (Retrievable), Endovascular Stent Graft - ... the major market drivers, restraints, and ... , Browse 108 market data tables ...
Breaking Medicine News(10 mins):Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5
... , , ... cell volume measurement in the flexographic printing industry, will be ... is a highly versatile, lightweight instrument that is extremely accurate ... The MicroDynamics QC line of inspection microscopes have a reputation ...
... U.S. survey of Internet players finds , TUESDAY, Aug. ... not the stereotypical adolescent locked to a computer screen ... survey, are 35-year-old adults, many of whom are overweight, ... findings also show that the health consequences of video ...
... of Health have found that the activity of a protein ... brain cancer called glioblastoma multiforme (GBM). In a move toward ... block this activity and reduce the spreading of GBM cells ... form of brain cancer, with about half of patients expected ...
... specific protein on the surface of a common bacterial ... enter the brain, initiating the deadly infection known as ... improved vaccines to protect those most vulnerable, including young ... the Journal of Experimental Medicine . "Streptococcus ...
... /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) www.htdsmedical.com ... report that its clinical trial is currently being processed. The ... 60 days). The company expects the manufacturing license will be ... (referred to as "swine flu" early on) is a new ...
... , Hospitals, Physicians Work Together ... PRINCETON, N.J., Aug. 18 Twelve New Jersey hospitals and ... test an innovative new incentive method that aims to reduce healthcare ... The three-year trial program could serve as a basis to overhaul ...
Cached Medicine News:Health News:Video Gamers Older Than You Think 2Health News:Video Gamers Older Than You Think 3Health News:Video Gamers Older Than You Think 4Health News:NIH researchers identify key factor that stimulates brain cancer cells to spread 2Health News:NIH researchers identify key factor that stimulates brain cancer cells to spread 3Health News:How meningitis bacteria attack the brain 2Health News:How meningitis bacteria attack the brain 3Health News:Hard To Treat Diseases (HTDS.PK) H1N1 Swine Flu Clinical Trial 2Health News:Hard To Treat Diseases (HTDS.PK) H1N1 Swine Flu Clinical Trial 3Health News:Medicare Picks N.J. to Test Innovative Incentive System 2Health News:Medicare Picks N.J. to Test Innovative Incentive System 3Health News:Medicare Picks N.J. to Test Innovative Incentive System 4
... The AquaFlow™ Collagen Glaucoma Drainage Device ... sclerectomy procedure has been proven to ... both the complications often associated with ... for medications. As a result, patient ...
... Cruise Control is a ... as a filter between ... aspiration tubing that captures ... safety and efficiency of ...
... Xpress is an innovative, stat analyzer that ... with on-board co-oximetry and integrated data management ... tests include pH, PCO 2 , PO ... hemoglobin, sodium, potassium, chloride, ionized calcium, ionized ...
... last 25 years, Bio-logic has demonstrated continuous ... that introduced the first Digital EEG system ... to you! Ceegraph VISION is the first ... expanded to integrate all your EEG needs: ...
Medicine Products: